100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
SOCRA CCRP EXAM ACTUAL EXAM 200 QUESTIONS AND CORRECT DETAILED ANSWERS WITH RATIONALES $10.49   Add to cart

Exam (elaborations)

SOCRA CCRP EXAM ACTUAL EXAM 200 QUESTIONS AND CORRECT DETAILED ANSWERS WITH RATIONALES

 0 view  0 purchase
  • Course
  • 2024/2025
  • Institution
  • 2024/2025

SOCRA CCRP EXAM ACTUAL EXAM 200 QUESTIONS AND CORRECT DETAILED ANSWERS WITH RATIONALES ICH GCP Development Date - Answer️️ -April 30 1996 ICH Q - Answer️️ -Quality ICH E - Answer️️ -Efficacy ICH S - Answer️️ -Safety ICH M - Answer️️ -Multidisciplinary ICH E 6 - Answer�...

[Show more]

Preview 3 out of 27  pages

  • September 18, 2024
  • 27
  • 2024/2025
  • Exam (elaborations)
  • Questions & answers
  • 2024/2025
  • 2024/2025
avatar-seller
EmillyCharlotte
TITLE: EMILLYCHARLOTTE 2024/2025 ACADEMIC PERIOD
OWNER: EMILLYCHARLOTTE
COPYRIGHT STATEMENT: ©2024 EMILLYCHARLOTTE. ALL RIGHTS RESERVED
FIRST PUBLISHED: SEPTEMBER 2024

SOCRA CCRP EXAM 2024-2025 ACTUAL EXAM
200 QUESTIONS AND CORRECT DETAILED
ANSWERS WITH RATIONALES

ICH GCP Development Date - Answer✔️✔️-April 30 1996


ICH Q - Answer✔️✔️-Quality

ICH E - Answer✔️✔️-Efficacy

ICH S - Answer✔️✔️-Safety

ICH M - Answer✔️✔️-Multidisciplinary

ICH E 6 - Answer✔️✔️-guidance for industry, consolidated guideance

ICH E2A - Answer✔️✔️-Clinical Safety Data Management Definitions and Standards

ICH S7A - Answer✔️✔️-Safety pharmacology studies for human pharmaceuticals

21 CFR Part 11 - Answer✔️✔️-Electronic records, electronic signatures

21 CFR Part 50 - Answer✔️✔️-Informed Consent

21 CFR Part 54 - Answer✔️✔️-Financial Disclosures

21 CFR Part 56 - Answer✔️✔️-Institutional Review Board

21 CFR 312 - Answer✔️✔️-IND Application

21 CFR 314 - Answer✔️✔️-New Drug Application

21 CFR 812 - Answer✔️✔️-Investigational Device Exemption

,TITLE: EMILLYCHARLOTTE 2024/2025 ACADEMIC PERIOD
OWNER: EMILLYCHARLOTTE
COPYRIGHT STATEMENT: ©2024 EMILLYCHARLOTTE. ALL RIGHTS RESERVED
FIRST PUBLISHED: SEPTEMBER 2024

pre market approval of medical devices - Answer✔️✔️-21 CFR Part 814

Federal Research - Answer✔️✔️-45 CFR Part 46

Safety Pharmacology Studies (Pre-Clinical) - Answer✔️✔️-Studies that investigate the

potential undesirable PD effects of a substance on physiological functions in relation to

exposure in the therapeutic range or above

Drug Development Safety Pharmacology Study Objectives (3) - Answer✔️✔️-1) To

Identify undesirable PD properties of a substance that may have relevance to its human

safety.

2) To evaluate adverse PD and/or pathophysio effects of a substance observed in

toxicology studies

3)to investigate the mechanism of the adverse PD effects observed and/or suspected

Three vital organ considered highest priority - Answer✔️✔️-1) Cardiovascular

2)Respiratory

3)CNS

Types of Non-Clinical Studies (Animal Trials) - Answer✔️✔️-1) PK and toxicokinetic

2) Single dose toxicity

3) Repeated dose toxicity

4) Local tolerance

5) Genotoxicity

6) Carcinogenicity

7) Reproduction toxicity

, TITLE: EMILLYCHARLOTTE 2024/2025 ACADEMIC PERIOD
OWNER: EMILLYCHARLOTTE
COPYRIGHT STATEMENT: ©2024 EMILLYCHARLOTTE. ALL RIGHTS RESERVED
FIRST PUBLISHED: SEPTEMBER 2024
8) Supplemental studies if needed

Primary Pharmacodynamic Studies - Answer✔️✔️-Study that investigates the mode of

action and/or effects of a drug substance in relation to its desired therapeutic target

Secondary Pharmacodynamic Studies - Answer✔️✔️-Studies that investigate the mode

of action and/or effects of a drug substance not related to its desire therapeutic target

Core Battery for Cardiovascular System - Answer✔️✔️-Blood Pressure

Heart Rate

ECG/EKG

Repolarization/conductance abnormalities

Core Battery for Respiratory System - Answer✔️✔️-Respiratory Rate

Functional Assessments (tidal volume, hgb Oxygen saturation)

Core Battery for Central Nervous System - Answer✔️✔️-Motor activity

behavioral changes

coordination

sensory/motor reflex response

temperature

Before clinical trials can be initiated, an application containing the appropriate

information must be submitted to regulatory authorities, in the USA this is called XXXX

and submitted to the XXX (21 CFR Part 312) - Answer✔️✔️-Investigational New Drug

Application

FDA

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller EmillyCharlotte. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for $10.49. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

74735 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy study notes for 14 years now

Start selling
$10.49
  • (0)
  Add to cart